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Abstract 
Background: Respiratory muscle strength declines in certain disease states, 
leading to impaired cough, reduced airway clearance and an increased risk of 
aspiration pneumonia. Respiratory muscle training may therefore reduce this 
risk. 
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Objectives: To assess current evidence of expiratory muscle strength training 
(EMST) on maximum expiratory pressure, cough flow and spirometry.  
Data sources: Databases including CINAHL, Medline, Science Direct and PEDRo 
were searched. 
Eligibility Criteria: Randomised controlled trials investigating expiratory muscle 
strength training on maximum expiratory pressure, pulmonary function or cough 
in any adult population, published before December 2017. 
Study appraisal: Data were extracted to a trial description form and study quality 
evaluated by 2 reviewers. Meta-analysis was performed with calculation of mean 
differences and 95% confidence intervals. 
Results: Nine studies met inclusion criteria and ranged in size from 12 to 42 
participants. Trials investigated EMST in healthy adults (2), multiple sclerosis (3), 
COPD (2), acute stroke (1) and spinal cord injury (1). Overall, EMST improved 
maximum expiratory pressure (15.95cmH2O; 95% CI: 7.77 to 24.12; p<0.01) 
with no significant impact on cough flow (4.63L/min; 95%CI -27.48 to 36.74; 
P=0.78), forced vital capacity (-0.16L; 95%CI -0.35 to 0.02; P=0.09) or forced 
expiratory volume in 1 second (-0.09L; 95%CI -0.10 to -0.08; P<0.001) versus 
control or sham training. 
Conclusions: Meta-analysis indicated a small significant increase in maximum 
expiratory pressure following EMST. Improvements in maximum expiratory 
pressure did not lead to improvements in cough or pulmonary function.  
Limitations: Variations in protocol design and population limited the overall effect 
size.   
Funding: None 
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Systematic Review Registration: PROSPERO (CRD42018104190).  
 
Contribution of Paper 
This review synthesises current EMST data on expiratory strength, pulmonary 
function and cough.  
Despite differences in intervention protocols, meta-analysis indicated a small but 
statistically significant increase in maximum expiratory pressure following 
training.  Few studies included secondary outcome measures of pulmonary 
function and cough flow with no evidence to support any change in airflow 
measures following EMST versus control or sham intervention. 
The functional relevance of maximum expiratory pressure gains is yet to be 
determined. Physiotherapists and clinicians involved in pulmonary rehabilitation 
or with patients prone to aspiration should be advised that use of EMST alone for 
improving airway clearance mechanics is not supported.  Further evidence of the 
relationship between expiratory strength and airway clearance is needed before 
EMST alone could be justified clinically to prevent aspiration. 
 
Keywords: Expiratory muscle strength training, maximum expiratory pressure, 
aspiration pneumonia. 
 
INTRODUCTION 
Respiratory muscle function is vital for life: creating pressure differences needed 
for ventilation, eliminating airway secretions and protecting the airways [1].  
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Respiratory muscle strength and pressure is known to decline progressively with 
increasing age [2], possibly leading to inadequate ventilation and undermining 
normal airway protection [1]. Certainly the increased frequency of aspiration 
pneumonia in the elderly has been attributed to impaired airway protection such 
as reduced peak expiratory flow and cough [3].  Impaired respiratory strength is 
also observed in several disease states including chronic obstructive pulmonary 
disease (COPD) [4], Parkinson’s disease (PD) [5,6], multiple sclerosis (MS) [7,8] 
and stroke [9], with reduced airway protection increasing the risk of aspiration 
pneumonia and hospital admission [10-12]. For this reason, respiratory muscle 
training becomes interesting as a strategy to reduce mortality from pneumonia. 
 
The respiratory musculature comprises inspiratory and expiratory muscles with 
focus, to date, on inspiratory muscle training (IMT). Studies in healthy 
populations have demonstrated positive changes in respiratory muscle strength 
and diaphragm mobility following IMT [13,14] with similar findings in patients 
with stroke, MS and PD [15,16].  Evidence also suggests respiratory weakness 
varies between diseases with expiratory muscles shown to weaken to a lesser 
extent than inspiratory in patients with COPD [17], but to a greater extent in MS 
[18]. From a functional perspective, expiratory muscles are known to have high 
activation for force generation during cough [19], therefore, specific expiratory 
weakness and impaired airway clearance may be responsible for the increased 
incidence of aspiration in patients prone to respiratory decline. Certainly studies 
in stroke suggest impairment of cough function is due to weakness of expiratory 
muscles rather than dysfunction at the level of the glottis [9]. Interventions 
targeting expiratory muscle strength therefore provide an attractive prophylaxis 
against aspiration pneumonia. 
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Studies of Expiratory Muscle Strength Training (EMST) on maximum expiratory 
pressure (MEP) have been performed in different populations, but there is no 
consensus on the effects of EMST on MEP, airway clearance or other pulmonary 
measures with no systematic reviews or meta-analyses and just one narrative 
review published to date [20]. 
 
Consequently the aim of this systematic review was to investigate evidence for 
EMST on MEP in health and disease states. A secondary objective was to identify 
whether EMST alters spirometry or cough measures. 
  
Review question 
Does expiratory muscle strength training affect maximum expiratory pressure, 
cough flow or spirometry in adult populations? 
 
Methods 
Systematic Review and Meta Analysis 
This quantitative systematic review protocol was prospectively registered with 
PROSPERO (CRD42018104190).  
Search Strategy 
A three-step search strategy was used.  An initial, limited search of Medline and 
CINAHL was followed by analysis of text words and index terms. Using keywords 
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identified, a second search was undertaken using CINAHL, Medline, Science 
Direct, PEDRo and Cochrane Central Register for Controlled Trials. All databases 
were searched from inception to end December 2017. Search terms were: 
Expiratory muscle strength training; expiratory training; OR Respiratory muscle 
strength training; AND expiratory pressure, maximum expiratory pressure, 
cough, sputum clearance. In a third step, references of retrieved studies were 
searched to identify further publications. To minimise publication bias, ‘grey’ 
literature was searched using Google Scholar. Due to limited resources for 
translation, only articles published in English were included.   
Study Design 
Randomised controlled trials (RCTs) only.  
Participants 
Studies of healthy adults and those with pulmonary, neurological or 
neuromuscular conditions were included. No upper age limit was defined. 
Interventions and Comparators 
Reports of threshold or resistance EMST were included. Combinations of 
interventions were excluded (e.g. inspiratory and expiratory training). 
Comparators were control intervention, sham EMST or breathing exercises. 
Outcome Measures 
The primary outcome measure was MEP. Secondary outcome measures included 
forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and 
peak expiratory cough flow (PECF).  
Study selection 
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On search completion, references were exported to Refworks, with duplicates 
identified and removed. Titles and abstracts were independently screened 
against inclusion criteria by two reviewers (LT and FR) and inclusion validated by 
discussion and consensus.  
Quality Assessment 
Methodological quality of each eligible article was assessed by two reviewers 
using the Critical Appraisal Skills Programme (CASP) RCT checklist [21]. Articles 
were assessed for risk of bias with any disagreement between reviewers resolved 
through discussion. In line with the Cochrane method, no quality threshold was 
defined with which to exclude studies, and only trials with RCT designs included 
[22].  
Data Extraction, Synthesis and Analysis 
Study details were extracted to a trial description form. Where sufficient 
information was available, Forrest plots were constructed using standardised 
mean differences for MEP, FVC, FEV1 and cough, based on post intervention 
means. 
Statistical heterogeneity was assessed using the inconsistency statistic I2 [23].  
All analyses were performed using Review Manager Software, version 5.0 
(Cochrane Collaboration 2011, 5.0). 
 
Results  
Study Inclusion 
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Literature searching identified 426 titles with 141 duplicates. Of the 285 
abstracts screened, 31 were retrieved for full text review, of which nine 
[7,17,18,24-29] met all inclusion criteria and underwent quality assessment, 
data extraction and analysis (Fig. 1).  
Methodological Quality  
All studies reported random allocation of participants in an effort to reduce 
selection bias, however assessment of true randomisation was not possible as no 
studies provided recruitment sampling methods. Blinding of participants and staff 
to group allocation was performed in six studies [7,24-29]. Compliance of 
attrition reporting was high with rates from 0 [17,29] to 23 [26] patients, with 
varied reasons for attrition. Of note, Gosselink et al. [18] reported patients who 
were unable to perform MEP measurements due to severely impaired lung 
function.  
Study Description: RCTs investigated EMST in healthy individuals (2 [17,29]), 
patients with COPD (2 [35,28]) and subjects with neurological conditions 
including MS (3 [7,18,27]), spinal cord injury (SCI; 1 [26]) and acute stroke (1 
[24]).  
Participants  
The number of study participants ranged from 12 [17] to 42 [24], with 236 
participants across all studies. Only Gosselink et al. [18] and Kulnik et al. [24] 
performed power analysis for sample size calculation.  
Subjects’ mean age ranged from 24 [29] to 66 years [25]. As neither Smeltzer et 
al. [7] nor Silverman et al. [27] reported participant age, a mean age across 
studies could not be calculated (Table 1).   
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Intervention and comparators  
All studies used threshold/resistance loading of the expiratory muscles although 
training devices varied between studies (Table 2) with five using a modified 
Threshold Inspiratory Muscle Trainer [7,17,18,25,28] and three using a 
Threshold Positive Expiratory Pressure (PEP) device [24,27,29]. Roth and 
colleagues [26] used a closed end, high-pressure force meter with subjects 
exhaling maximally against a pressure gauge. All studies assessed MEP as a 
primary outcome measure with three including cough [18,24,29] or spirometry 
outcomes [25,26,29]. 
Of the included studies, only those in healthy subjects [17,29] compared EMST 
to a control with no intervention. All remaining studies included breathing 
exercises [18] or sham EMST as a comparator [7,24-28].  
 
Outcome 1: Expiratory Muscle Strength 
Overall meta-analyses included a total of 213 patients and favoured EMST 
intervention with a small but significant improvement in MEP of 15.95 cmH2O 
(95% CI: 7.77 to 24.12; p<0.001; Fig 2A) compared with control/sham. To 
investigate sources of heterogeneity (I2>50%) across studies, sub-analyses were 
performed by pathology. 
Healthy Populations 
In both RCTs investigating EMST with healthy subjects [17,29], populations were 
of similar age (mean age ≤30) with baseline MEP values in line with reported 
norms [30] and no significant differences between groups at baseline. Both 
studies used a 4-week 30% threshold training programme comprising two 15-
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minute sets of training daily for 4 weeks. Each reported significant increases in 
MEP versus control. Meta-analysis comprised 34 healthy participants, with high 
homogeneity (I2=0%), suggesting EMST significantly improved MEP with a mean 
difference of 33.62cmH20 (95%CI 16.38 to 50.85; p<0.0001) versus control (Fig 
2B).  
 
COPD 
Two studies investigated MEP in patients with COPD [25,28]. Whilst both 
reported no difference between groups at baseline, actual MEP values varied 
considerably between studies. Weiner et al. [28] reported lower baseline MEP 
than predicted values for the equivalent age category [31], whilst Mota et al. 
[25] recorded pressures greater than some reported norms for MEP [30] Despite 
these differences, both studies trained muscle endurance with 30-minute training 
sessions at 50-60% of MEP, although Weiner [28] used a longer 12-week 
training period. Forrest plots identified good homogeneity between studies 
(I2=0%) and meta-analysis, with a total of 39 patients with COPD, suggested 
EMST significantly improved MEP in COPD with a standard mean difference of 
19.93cmH20 (8.88 to 30.97; p=0.0004) versus control (Fig 2C).  
Multiple Sclerosis 
Three studies investigated MEP in patients with MS [7,18,27]. Gosselink (2000) 
and Smeltzer (1996) reported reduced baseline MEP to 29% [18] and 36.9% [7] 
of predicted normative values respectively. The most recent study [27] reported 
higher baseline MEP values with no comparison to normal values.  
All three studies used a similar protocol using daily sets (15-25 repetitions) of 
MEP at 50%, 75% or maximal resistance. The earlier studies [7,18] both 
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employed a 12-week protocol and reported significant improvements in MEP 
following EMST. Meta-analysis of the three studies, with a total of 69 patients 
showed considerable heterogeneity (I2=61%) and no significant change in MEP 
following EMST (11.29cmH20 (-0.32 to 22.91; p<0.06) versus sham (Fig 2D). 
Stroke  
One study [24] investigated EMST in patients within 2 weeks of stroke onset 
(n=42). Baseline MEP values were not significantly different between groups but 
reduced compared to age-matched normal values. Only 52% of patients 
completed more than 70% of the 4-week training programme with significant 
improvement in MEP in intervention and control groups (Mean (SD) change in 
MEP EMST 12(15)cmH20 versus sham 12(18) cmH20, p=0.35). 
Spinal Cord Injury 
One RCT [26] investigated EMST in 29 patients with motor-complete spinal cord 
injury at or above T1. There was no difference between groups at baseline with 
MEP lower than age-matched norms [31]. Following a strength training protocol 
of 10 maximal expirations twice daily for 6-weeks, significant improvements in 
MEP were seen in the training group versus sham (Mean (SD) change in MEP 
EMST 35(38.4)cmH20 versus sham 8(19.1) cmH20, p=0.002).  
Outcome 2: Cough  
Three studies included cough as a secondary outcome measure [18,24,29]. 
Sasaki [29] and Kulnik et al. [24] assessed PECF outcomes following 4-week 
EMST in healthy subjects and patients following acute stroke, respectively.  
Baseline PECF was normal in patients after acute stroke [24]. Both intervention 
and sham groups demonstrated increases in PECF over time, with no significant 
difference between groups. In healthy subjects, Sasaki [29] found no change in 
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PECF following EMST. Despite differences in age and baseline MEP, PECF data 
between studies showed good homogeneity (I2=8%) and indicated no significant 
impact of EMST on PECF (4.63L/min; 95%CI -27.48 to 36.74; P=0.78; Figure 3).  
Gosselink et al. [18] assessed cough efficacy by means of the validated 
pulmonary index (PI) for patients with MS [32], reporting significant 
improvements versus control following EMST. The PI includes patient- and 
examiner-rated ability to clear the airway, however the authors provided no 
detail on components of the index that improved following training.  
Outcome 3: Pulmonary Function 
Three studies [25,26,29] included pulmonary function as outcome measures, 
reporting FEV1 or FVC. Roth et al. [26] demonstrated small increases in FVC and 
FEV1 in intervention and sham groups, whilst Mota [25] and Sasaki [29] found no 
change in any measure of pulmonary function following EMST. Forrest plots 
indicated good homogeneity (I2=0%) with no evidence to support EMST in 
improving FVC (-0.16L; 95%CI -0.35 to 0.02; P=0.09; Fig 4A) or FEV1 (-0.09L; 
95%CI -0.10 to -0.08; P<0.001; Fig 4B). 
 
Discussion  
This review aimed to assess the evidence for EMST on maximum expiratory 
pressure in different adult populations.  Meta-analysis indicated a small but 
significant increase in expiratory pressure following EMST, representing an 
improvement of approximately 15% in MEP. There was no evidence of any effect 
of EMST on peak cough flow or spirometry.  
As expiratory training is a potential intervention to improve airway clearance, 
determining its effectiveness by clinical population is paramount. Further meta-
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analysis by patient population also indicated an increase in MEP following 
expiratory training that reached significance in young healthy adults and those 
with COPD, but not in patients with MS. This is in line with a recent Cochrane 
review of respiratory training in MS that failed to find sufficient evidence to 
support expiratory training or breathing exercises on MEP [33]. 
Only single RCTs were available in patients with SCI or stroke, precluding meta-
analysis. Similar to MS findings, data in patients following acute stroke showed 
no significant increase in MEP following training, however in patients with spinal 
cord injury, maximal resistance training significantly increased MEP. Differences 
in disease pathology across these groups may impact patients’ ability to comply 
with training and account for some of this variation. Facial weakness and reduced 
lip closure strength have been documented in patients with MS [34] and stroke 
[35] respectively, affecting ability to achieve and maintain a mouth seal during 
expiratory training. In the current MS studies, Gosselink et al, [18] excluded 
patients due to inability to generate mouth pressures, while Silverman et al, [27] 
mentioned insufficient facial strength as possible exclusion criteria. As each of 
these studies used near-maximal or maximal strength training, it is conceivable 
that difficulties maintaining the buccal pressures generated during EMST may 
have limited the effects of muscle training. Conversely in patients following SCI, 
where oromotor control is not routinely affected, maximal resistance training was 
tolerated resulting in significant improvements in MEP versus control.  
In COPD, where evidence suggests that up to 20% of patients with severe 
disease have insufficient inspiratory strength to generate peak flow requirements 
for inhalation delivery devices [36], patients tolerated EMST well with a 
significant increase seen in MEP. This may be due to use of a lower intensity 
“resistive breathing” protocol (up to 60% expiratory pressure training), rather 
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than strength-based near maximal “threshold loading”. Although resistive 
breathing and threshold loading have been shown to generate similar workloads 
in inspiratory training [37], the higher pressures generated during maximal 
resistance loading may not be tolerable in patient populations prone to 
respiratory muscle weakness.  
The small effect size of EMST may have been due to the lack of a standardized 
intervention protocol and duration across studies. Firstly, the different training 
devices used were neither designed nor validated for expiratory muscle training. 
The Threshold IMT is validated as a reliable method of loading inspiratory 
muscles [38] but there is no equivalent study on modification for expiratory 
loading. Similarly, Threshold PEP was designed as an adjunct to mobilise airway 
secretions and prevent atelectasis, with studies validating its reliability for 
muscle training/loading lacking.  
Secondly, a lack of training specificity may also have weakened the size of the 
training effect seen. In terms of muscle physiology, short 4-week periods of 
training are sufficient to initiate neural changes such as increased motor unit 
recruitment and firing rates [39], but not to elicit changes in muscle fibre 
strength [39]. Current studies in healthy individuals both identified increases in 
MEP after just 4 weeks in line with broader literature [40]. However, evidence 
suggests training programmes of at least 6 weeks duration, are needed to 
generate sustainable, measurable changes in muscle fibre hypertrophy [41]. 
From a clinical perspective, as post-intervention MEP values in COPD, stroke and 
MS studies all remained below normal for their respective age category [30], 
extending the duration of EMST may have been more effective in achieving 
outcomes closer to normal/predicted MEP levels, although patient adherence to 
longer interventions may prove difficult.  
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Gains of 15% expiratory strength may represent statistically significant changes 
in MEP, however the clinical significance of these changes is unclear. Critical MEP 
levels have been proposed (40cmH20), below which secretions are thought to 
accumulate in the larynx [42], however the minimal MEP improvement needed to 
impact airway clearance has yet to be determined. Correlations between MEP 
and cough have been documented in SCI where a 10cmH20 increase in MEP has 
been shown to generate 0.15L/sec improvements in PECF [43], however the 
functional benefits of this have not been determined.  The current meta-analysis 
did not support EMST effects on cough flow, with several factors likely affecting 
this. In addition to the paucity of data, the lack of cough flow impairment in the 
populations studied may have limited the potential for improvement, there may 
have been insufficient improvement in MEP in order to impact cough efficacy, or 
these findings may be the result of inadequate training specificity.  It has been 
suggested that expiratory muscles need to be trained close to residual volume to 
improve expiratory capacity and flow [32], however current studies performed 
training closer to total lung capacity. This highlights the importance of accurate 
intervention design and the selection of outcome measures that are proven to be 
sensitive to the intervention in question.  It may be that other measures of 
cough, such as the pulmonary index [18], are more sensitive to changes in MEP. 
In line with previous quasi-experimental studies [8] current meta-analysis 
suggested no significant effect of EMST on either FEV1 or FVC.  Proposed 
explanations for this suggest elastic recoil and properties of the lung tissue, 
rather than expiratory muscle strength, may determine maximum expiratory 
flow [29]. Certainly changes to lung tissue in chronic diseases such as MS are 
known to impair lung compliance to a greater extent than skeletal muscle 
weakness [8]. One recent systematic review has suggested combined expiratory 
and inspiratory training may have a greater impact on pulmonary function by 
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enhancing inspiratory reserve volume and elastic recoil, and generating 
significant improvements in FEV1 [44].  
Limitations  
The potential to overestimate the current treatment effect, due to the small 
number of eligible studies, small sample sizes, variation in age, population and 
intervention design, must be considered when interpreting the present results.  
Conclusion  
This review aimed to assess and synthesise current EMST data and determine 
the effect of EMST on expiratory strength, pulmonary function and cough. Nine 
studies examined MEP as a primary outcome measure and, despite differences in 
intervention protocols, meta-analysis indicated a small but statistically significant 
increase in MEP following EMST.  Limited studies included outcome measures of 
pulmonary function or cough with no evidence to support any change in airflow 
measures following EMST. 
Implications for Research 
Methodological variation across studies offers direction for future research to 
determine the most effective training protocol for MEP gains. As cough and 
spirometry measures were not sensitive to MEP changes, investigation of other 
functional outcomes such as dyspnoea may help identify a role for improvements 
in MEP. Future EMST research may best be conducted as one arm of larger 
interventions using combined inspiratory and expiratory muscle training.  
Implications for Clinical Practice 
Populations prone to expiratory muscle weakness have been shown to respond to 
EMST, however the functional relevance of this is yet to be determined. As a link 
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has not yet been demonstrated between increased MEP and improved airway 
clearance, physiotherapists and clinicians involved in treatment of patients prone 
to aspiration should undertake EMST with caution. 
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Figure 1: PRISMA Flowchart of Search and Selection Criteria 
 
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For	more	information,	visit	www.prisma-statement.org. 
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Table 1: Characteristics of Included Studies  
Study (year) 
Country [ref] 
Patients 
(N, mean age, sex) 
Population Outcome measures Key Findings 
MEP PFT Cough  
Sasaki (2007) 
Japan [29] 
N=33, 24y, 70% male 
(n=22 completed) 
Healthy ✓ FVC FEV1 PECF * MEP improved in EMST group compared with control 
(p<0.05), with no change in spirometry or PECF 
Suzuki et al. 
(1995)  
Japan [17] 
N=12, 30y, 100% male Healthy ✓ - - * MEP improved in EMST group compared with control 
(p<0.05).  
Gosselink et al. 
(2000) 
Belgium [18] 
N=21, 58y, 46% male 
(n=18 completed) 
MS ✓ - PI No significant increase in MEP post training.  
 PI increased (p<0.05) vs baseline and control. 
Silverman 
(2017)  
USA [27] 
N=42, not reported, 
26% male 
(n=36 completed) 
MS ✓ - - No significant increase in MEP post training vs sham 
Smeltzer et al. 
(1996)  
USA [7] 
N=15, not reported, 
46% males 
MS ✓ - - * MEP increased (p<0.005) post training vs sham. 
Mota et al. 
(2007)  
Spain [25] 
N=16, 66y, 100% male COPD 
GOLD III & IV 
✓ FVC FEV1 - * MEP improved in EMST group vs sham (p<0.05), 
with no significant changes in spirometry. 
Weiner et al., 
(2003)  
Israel [28] 
N=26, 62y, 85% male 
(n=23 completed) 
COPD, GOLD 
III & IV 
✓ 
 
- - * MEP improved in EMST group compared with control 
(p<0.05) 
Kulnik et al. 
(2015)  
UK [24] 
N=42, 64y, 65% male 
 
Stroke ✓ - PECF MEP and PEFR improved in treatment and sham 
groups with no significant differences due to training. 
Roth et al. 
(2010)  
USA [26] 
N=29, 30y, 76% male SCI ✓ FVC, FEV1 - MEP increased in training and sham groups but only 
reached significance in training group (p<0.05) with 
no significant changes in spirometry. 
Abbreviations: N: number of subjects; y: years; MS: multiple sclerosis; COPD: chronic obstructive pulmonary disease; GOLD: Global initiative for 
Chronic Obstructive Lung Disease classification; SCI: spinal cord injury; MEP: maximum expiratory pressure; PFT: pulmonary function tests; FVC: 
forced vital capacity; FEV1: forced expiratory volume in 1 second; PI: pulmonary index; PECF: peak expiratory cough flow; vs: versus; EMST: 
expiratory muscle strength training, * significant change (p<0.05) in MEP vs control/sham. 
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Table 2 Expiratory Muscle Strength Training - Intervention Parameters  
 
Study 
(year) 
Subjects Threshold 
Intensity 
Time/
reps 
Frequency  
(times per 
week) 
Duration 
(weeks) 
Comparator  Device 
Sasaki  
(2007) [29] 
Healthy 30% 2x15 
min 
7 4 Control* PEP 
Suzuki et al. 
(1995)[17] 
Healthy 30% 2x15 
min 
7 4 Control* Threshold 
IMST 
Mota et al. 
(2007) [25] 
COPD 50% 30 min 3  5 Sham* Threshold 
IMST 
Weiner et al. 
(2003) [28] 
COPD 15-60% 30 min 6  12 Control* Threshold 
IMST 
Gosselink et 
al. (2000)[18] 
MS 60% 6x15 
reps 
7 12 Control  Threshold 
IMST 
Silverman et 
al. (2017) 
[27] 
MS 75% 5x5 
reps 
5 5 Sham** PEP 
Smeltzer et 
al. (1996) [7] 
MS Patient- 
selected 
maximum 
6x15 
reps 
7 12 Sham* Threshold 
IMST 
Kulnik et al. 
(2015) [24] 
Stroke 50% 5x10 
reps 
7 4 Sham** PEP 
Roth et al. 
(2010) [26] 
SCI Maximum 
resistance 
2x10 
reps 
5 6 Sham* Closed end 
pressure 
meter 
* Significant change (p<0.05) in MEP vs control/sham; ** significant increase in MEP vs 
baseline but not vs sham. 
Abbreviations: MS: multiple sclerosis; COPD: chronic obstructive pulmonary disease; 
SCI: spinal cord injury; PT: physiotherapy. *Significant (p<0.05) increase in MEP 
following EMST vs control/sham.  
 
 
Figure 2: Forrest plots illustrating change in maximum expiratory pressure (MEP) 
following expiratory muscle strength training (EMST) versus control: (A) all 
studies; (B) healthy subjects; (C) chronic obstructive pulmonary disease 
(COPD); (D) multiple sclerosis (MS). 
A) All studies 
 
B) Healthy 
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C) COPD 
 
D) MS  
 
Figure 3: Forrest plot of change in peak expiratory cough flow (PECF) following 
expiratory muscle strength training (EMST) versus control 
 
Figure 4: Forrest plot illustrating change in A) Forced vital capacity (FVC) or B) 
Forced expiratory volume in 1 second (FEV1) following expiratory muscle 
strength training (EMST) versus control. 
A) FVC 
 B) FEV1
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